Wang Xiaodong, Abliz Paride, Deng Shuwen
Department of Dermatology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, People's Republic of China.
Department of Medical Microbiology, People's Hospital of Suzhou New District, Suzhou, Jiangsu, People's Republic of China.
Infect Drug Resist. 2023 Mar 1;16:1231-1236. doi: 10.2147/IDR.S400068. eCollection 2023.
Macrolide resistance in () has been increasing in recent years worldwide. However, few data are available on macrolide resistance in from Xinjiang province, located in the western part of China, which is an area with a high incidence of syphilis. In this study, we investigated the molecular characteristics of macrolide resistance in from patients with latent syphilis in Xinjiang, China.
In total, 204 whole blood samples were collected from patients with latent syphilis during 2016 to 2017, in the First Hospital of Xinjiang Medical University. Genomic DNA of blood samples was extracted using a QIAamp DNA Mini Kit and was detected by PCR with the specific gene of . The 23S rRNA gene of was amplified among the -positive samples by nested PCR, and macrolide resistance-associated mutation sites A2058G and A2059G in the 23S rRNA gene were identified using restriction enzymes II and I.
The specific gene of ( positive) was detected in 27 blood samples (13.2%) from 204 patients with latent syphilis. The 23S rRNA gene was then amplified in all 27 -positive samples, among which 24/27 samples (88.9%) harbored the A2058G mutation in the 23S rRNA gene and 3/27 (11.1%) had the A2059G mutation.
Our results indicated that macrolide resistance should not be ignored in Xinjiang, China, and that A2058G was the predominant macrolide resistance mechanism. Blood may be a suitable specimen for the detection of resistant mutations of in patients with latent syphilis who do not show any clinical symptoms.
近年来,全球范围内淋病奈瑟菌对大环内酯类药物的耐药性一直在增加。然而,关于中国西部梅毒高发地区新疆的淋病奈瑟菌大环内酯类耐药性的数据却很少。在本研究中,我们调查了中国新疆潜伏梅毒患者中淋病奈瑟菌大环内酯类耐药的分子特征。
2016年至2017年期间,在新疆医科大学第一附属医院共采集了204份潜伏梅毒患者的全血样本。使用QIAamp DNA Mini试剂盒提取血样的基因组DNA,并通过针对淋病奈瑟菌特异性基因的PCR进行检测。在淋病奈瑟菌阳性样本中,通过巢式PCR扩增淋病奈瑟菌的23S rRNA基因,并使用限制性内切酶II和I鉴定23S rRNA基因中与大环内酯类耐药相关的突变位点A2058G和A2059G。
在204例潜伏梅毒患者的27份血样(13.2%)中检测到淋病奈瑟菌特异性基因(阳性)。然后在所有27份淋病奈瑟菌阳性样本中扩增23S rRNA基因,其中24/27份样本(88.9%)在23S rRNA基因中存在A2058G突变,3/27份样本(11.1%)存在A2059G突变。
我们的结果表明,在中国新疆,淋病奈瑟菌大环内酯类耐药不容忽视,且A2058G是主要的大环内酯类耐药机制。对于没有任何临床症状的潜伏梅毒患者,血液可能是检测淋病奈瑟菌耐药突变的合适标本。